LEGN
Legend Biotech Corp
$59.99
Earnings Summary
Revenue | $96.01Mn |
Net Profits | $-62.21Mn |
Net Profit Margins | -64.79% |
Highlights
Legend Biotech Corp’s revenue jumped 250.91% since last year same period to $96.01Mn in the Q3 2023. On a quarterly growth basis, Legend Biotech Corp has generated 30.93% jump in its revenue since last 3-months.
Legend Biotech Corp’s net profit jumped 26.78% since last year same period to $-62.21Mn in the Q3 2023. On a quarterly growth basis, Legend Biotech Corp has generated 68.76% jump in its net profits since last 3-months.
Legend Biotech Corp’s net profit margin jumped 79.13% since last year same period to -64.79% in the Q3 2023. On a quarterly growth basis, Legend Biotech Corp has generated 76.14% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Legend Biotech Corp post its latest quarter earnings
EPS Estimate Current Quarter | -0.64 |
EPS Estimate Current Year | -0.64 |
Highlights
Legend Biotech Corp’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a -8.47% fall from last quarter’s estimates.
Legend Biotech Corp’s earning per share (EPS) estimates for the current year stand at -0.64.
Key Ratios
Key ratios of the Legend Biotech Corp post its Q3 2023 earnings
Earning Per Share (EPS) | -0.34 |
Highlights
Legend Biotech Corp’s earning per share (EPS) jumped 8.11% since last year same period to -0.34 in the Q3 2023. This indicates that the Legend Biotech Corp has generated 8.11% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-15 | -0.6 | -1.14 | -90% |
2023-03-31 | -0.78 | -0.68 | 12.82% |
₹0 US Stocks a/c Opening Fee